Small molecule therapy in UC: update 2025

 

Aim:

  1. To understand the MOA of novel small molecule immune-modulators;
  2. To Provide an evidence-based comparison of treatment efficacy of biologicals in UC;
  3. To provide an evidence-based comparison of treatment efficacy of small molecule immune-modulators in UC
Session date: 
11/12/2025 - 11:00am to 12:00pm EST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
    Children’s National Hospital designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Participation
    Successful completion of this continuing education activity.
Please login or register to take this course.
Faculty List: 
Speaker(s)

Carmelo Cuffari, MD, FRCP(C), FACG

has no relevant financial relationships to disclose at this time.